Experts are interested in using computed tomography as an investigative tool due to its ability to provide detailed information while also preserving historical artifacts. 

It can be difficult to deliver targeted therapy to the brain due to its protective barrier, which only allows certain nutrients and oxygen to pass through.

The technique highlights differences in how water molecules move through cancerous tissue in comparison to healthy tissue.

Experts hope the information gained from their research could help providers better determine whether patients will regain mobility after sustaining an injury. 

James Min, MD, Cleerly's founder and CEO, changed careers to address what he saw as a major unmet need in cardiology.